112 related articles for article (PubMed ID: 23201296)
1. The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer.
Uzunoglu FG; Heumann A; Musici S; Kutup A; Koenig A; Roch N; Thomssen A; Dohrmann T; Tsui TY; Mann O; Izbicki JR; Vashist YK
Lung Cancer; 2013 Feb; 79(2):151-5. PubMed ID: 23201296
[TBL] [Abstract][Full Text] [Related]
2. The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx.
Lehnerdt GF; Franz P; Winterhoff S; Bankfalvi A; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
Laryngoscope; 2008 Dec; 118(12):2172-6. PubMed ID: 19029852
[TBL] [Abstract][Full Text] [Related]
3. Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.
Lehnerdt GF; Franz P; Zaqoul A; Schmitz KJ; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
Clin Cancer Res; 2008 Mar; 14(6):1753-8. PubMed ID: 18347176
[TBL] [Abstract][Full Text] [Related]
4. The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist YK; Kutup A; Musici S; Yekebas EF; Mina S; Uzunoglu G; Zehler O; Koenig A; Cataldegirmen G; Bockhorn M; Effenberger K; Kalinin V; Pantel K; Izbicki JR
Cell Oncol (Dordr); 2011 Aug; 34(4):281-8. PubMed ID: 21340746
[TBL] [Abstract][Full Text] [Related]
5. The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.
Frey UH; Lümmen G; Jäger T; Jöckel KH; Schmid KW; Rübben H; Müller N; Siffert W; Eisenhardt A
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):759-63. PubMed ID: 16467086
[TBL] [Abstract][Full Text] [Related]
6. The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum.
Xie FJ; Zhao P; Kou JY; Hong W; Fu L; Hu L; Hong D; Su D; Gao Y; Zhang YP
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1443-8. PubMed ID: 22371153
[TBL] [Abstract][Full Text] [Related]
7. GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.
Schmitz KJ; Lang H; Frey UH; Sotiropoulos GC; Wohlschlaeger J; Reis H; Takeda A; Siffert W; Schmid KW; Baba HA
Neoplasia; 2007 Feb; 9(2):159-65. PubMed ID: 17356712
[TBL] [Abstract][Full Text] [Related]
8. [Association between GNAS1 T393C polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated advanced non-small cell lung cancer with unknown EGFR mutation status].
Hong W; Lin B; Zhang B; Mao W; Zhang Y
Zhongguo Fei Ai Za Zhi; 2014 Apr; 17(4):321-6. PubMed ID: 24758907
[TBL] [Abstract][Full Text] [Related]
9. GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer.
Frey UH; Alakus H; Wohlschlaeger J; Schmitz KJ; Winde G; van Calker HG; Jöckel KH; Siffert W; Schmid KW
Clin Cancer Res; 2005 Jul; 11(14):5071-7. PubMed ID: 16033819
[TBL] [Abstract][Full Text] [Related]
10. The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.
Frey UH; Eisenhardt A; Lümmen G; Rübben H; Jöckel KH; Schmid KW; Siffert W
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):871-7. PubMed ID: 15824158
[TBL] [Abstract][Full Text] [Related]
11. The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.
Frey UH; Nückel H; Sellmann L; Siemer D; Küppers R; Dürig J; Dührsen U; Siffert W
Clin Cancer Res; 2006 Oct; 12(19):5686-92. PubMed ID: 17020971
[TBL] [Abstract][Full Text] [Related]
12. C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC.
Uzunoglu FG; Yavari N; Bohn BA; Nentwich MF; Reeh M; Pantel K; Perez D; Tsui TY; Bockhorn M; Mann O; Izbicki JR; Wikman H; Vashist YK
Lung Cancer; 2013 Jul; 81(1):123-9. PubMed ID: 23548249
[TBL] [Abstract][Full Text] [Related]
13. Gender-dependent association of the GNAS1 T393C polymorphism with early aseptic loosening after total hip arthroplasty.
Bachmann HS; Hanenkamp S; Kornacki B; Frey UH; Bau M; Siffert W; Wedemeyer C
J Orthop Res; 2008 Dec; 26(12):1562-8. PubMed ID: 18634020
[TBL] [Abstract][Full Text] [Related]
14. The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma.
Otterbach F; Callies R; Frey UH; Schmitz KJ; Wreczycki C; Kimmig R; Siffert W; Schmid KW
Breast Cancer Res Treat; 2007 Nov; 105(3):311-7. PubMed ID: 17186357
[TBL] [Abstract][Full Text] [Related]
15. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
Alakus H; Bollschweiler E; Hölscher AH; Warnecke-Eberz U; Frazer KA; Harismendy O; Lowy AM; Mönig SP; Eberz PM; Maus M; Drebber U; Siffert W; Metzger R
Ann Surg Oncol; 2014 Dec; 21(13):4375-82. PubMed ID: 24986238
[TBL] [Abstract][Full Text] [Related]
16. [Association of T393C single nucleotide polymorphism of GNAS1 gene with non-valvular atrial fibrillation].
Li H; Hu Z; Tan Z; Hou Q; Peng J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1508-11. PubMed ID: 24144757
[TBL] [Abstract][Full Text] [Related]
17. Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer.
Alakus H; Mönig SP; Warnecke-Eberz U; Alakus G; Winde G; Drebber U; Schmitz KJ; Schmid KW; Riemann K; Siffert W; Bollschweiler E; Hölscher AH; Metzger R
World J Gastroenterol; 2009 Dec; 15(48):6061-7. PubMed ID: 20027678
[TBL] [Abstract][Full Text] [Related]
18. The T393C polymorphism of the Galphas gene (GNAS1) is associated with the course of Graves' disease.
Glowacka D; Loesch C; Johnson KT; Mann K; Esser J; Morgenthaler NG; Siffert W; Schmid KW; Eckstein AK
Horm Metab Res; 2009 Jun; 41(6):430-5. PubMed ID: 19513951
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
